Insiders · Profile

Dahan Michel

SVP, Chief Operating Officer at Akebia Therapeutics. Filing since 4 Apr 2016. CIK 0001669737

Company

Date

Role

Action

Shares

Amount

Of holding

AKBA Akebia Therapeutics, Inc.

13 May 2024

SVP, Chief Operating Officer

Sold on a plan

34,840

$43.90K

4.9%

AKBA Akebia Therapeutics, Inc.

29 Feb 2024

SVP, Chief Operating Officer

Sold at will

8,661

$13.68K

1.2%

AKBA Akebia Therapeutics, Inc.

27 Feb 2024

SVP, Chief Operating Officer

Sold at will

10,744

$16.33K

1.5%

AKBA Akebia Therapeutics, Inc.

25 May 2023

SVP, Chief Operating Officer

Sold at will

95,478

$116.76K

14.3%

AKBA Akebia Therapeutics, Inc.

1 Mar 2023

SVP, Chief Operating Officer

Sold, plan not stated

20,412

$17.91K

7.0%

AKBA Akebia Therapeutics, Inc.

27 Feb 2023

SVP, Chief Operating Officer

Sold, plan not stated

10,090

$8.21K

3.4%

AKBA Akebia Therapeutics, Inc.

1 Mar 2022

SVP, Chief Operating Officer

Sold, plan not stated

14,978

$32.51K

4.8%

AKBA Akebia Therapeutics, Inc.

28 Feb 2022

SVP, Chief Operating Officer

Sold, plan not stated

6,555

$14.12K

2.5%

AKBA Akebia Therapeutics, Inc.

1 Apr 2021

SVP, Chief Operating Officer

Sold, plan not stated

1,211

$4.12K

0.5%

AKBA Akebia Therapeutics, Inc.

1 Mar 2021

SVP, Chief Operating Officer

Sold, plan not stated

14,547

$49.40K

5.4%

AKBA Akebia Therapeutics, Inc.

28 Feb 2020

SVP, Chief Operating Officer

Sold, plan not stated

6,972

$60.66K

3.3%

AKBA Akebia Therapeutics, Inc.

2 Oct 2017

SVP, Chief Business Officer

Sold, plan not stated

1,398

$27.46K

1.4%

AKBA Akebia Therapeutics, Inc.

28 Sep 2017

SVP, Chief Business Officer

Sold, plan not stated

5,000

$96.50K

4.9%

AKBA Akebia Therapeutics, Inc.

15 Aug 2017

SVP, Chief Business Officer

Sold, plan not stated

5,000

$75.00K

4.7%

AKBA Akebia Therapeutics, Inc.

3 Jul 2017

SVP, Chief Business Officer

Sold, plan not stated

1,399

$19.95K

1.3%

AKBA Akebia Therapeutics, Inc.

3 Apr 2017

SVP, Chief Business Officer

Sold, plan not stated

1,401

$12.86K

1.3%

AKBA Akebia Therapeutics, Inc.

1 Jan 2017

SVP, Chief Business Officer

Sold, plan not stated

1,629

$17.09K

2.3%

AKBA Akebia Therapeutics, Inc.

1 Oct 2016

SVP, Chief Business Officer

Sold, plan not stated

1,401

$12.55K

1.9%

AKBA Akebia Therapeutics, Inc.

5 Jul 2016

SVP, Chief Business Officer

Sold, plan not stated

1,402

$10.47K

1.9%

AKBA Akebia Therapeutics, Inc.

4 Apr 2016

SVP, Chief Business Officer

Sold, plan not stated

1,401

$13.18K

1.8%

20 decisions on file.